Best Diversified Diagnostics Companies in India
The 96 best Diversified Diagnostics companies in India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Achira.
India's Diversified Diagnostics sector doesn't get nearly enough credit for the revenue it actually generates. This directory ranks 96 Diversified Diagnostics companies in India by disclosed equity funding and recent funding momentum, and the financials behind that list are worth sitting with. Across 48 filers, the combined revenue pool hits $165M, with a median of $474,208 per company growing at 7% YoY. Premier Medical Corporation pulled $29M in revenue, even after a sharp 50% YoY contraction. Medsource Ozone Biomedicals logged $21M at a steadier clip. And the net income story is frankly striking: Poct Science House, Medsource Ozone Biomedicals, and Premier Medical Corporation each earned roughly $3M in net income, putting them at 100x or more above the sector median of $23,640.
So what's driving this? The global market sits at roughly $3.0B and is forecast to reach $4.5B by 2030 at a 4.7% CAGR, pulled by point-of-care kit availability and rising chronic disease burden. Stringent regulatory approvals shape who can actually scale here, which helps explain why total disclosed funding across these 96 companies is only $20M, led by Achira at $10M. If you're mapping this space, I'd focus less on funding size and more on the revenue multiples the top earners are already generating. The capital is modest. The earnings aren't.
- ResearchAndMarkets.com
Ranked: Best Diversified Diagnostics companies in India
| # | Company | Disclosed funding | Revenue | Revenue YoY | Employees | Founded | Founder | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Transasia Bio-Medicals Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutions | — | $172M FY2025 | -9% | 1,295 1,295 → 2,135 (+65%) | 1979 | Nishant Saxena Global CEO | — |
| 2 | Integris Medtech | — | $82M FY2025 | +20% | — | 2008 | Probir Das Group Chief Executive Officer | — |
| 3 | Medsource Ozone Biomedicals In Vitro diagnostic solutions for clinical laboratories | $5M | $22M FY2025 | +5% | 375 | 2003 | Ajaykumar Bhatt CEO | 1 launch · 1 partnership |
| 4 | Rapid Diagnostics IVD and critical care devices | $3M | $12M FY2025 | +15% | 93 93 → 197 (+112%) | 1995 | Bharat Jindal Founder | — |
| 5 | Beacon Diagnostics Manufacturer of diagnostic reagents and instrument | — | $10M FY2025 | -1% | 259 | 1990 | Chirag Joshi CEO | — |
| 6 | Avecon Healthcare Develops rapid tests, kits, automated lab instruments and POC devices for disease diagnosis | — | $5M FY2023 | — | 25 | 2007 | Rajesh Aggarwal Founder | — |
| 7 | Biogeny Diagnostics Reagents and instruments for clinical diagnostic chemistry | — | $4M FY2023 | — | 86 | 2009 | Bruno Attilio Pizzochero Founder | — |
| 8 | Bio Lab Diagnostics Manufacturer and Exporter of Rapid IVD kits and analyzers | — | $4M FY2025 | +2% | — | 1987 | Hitendra Shah CEO | — |
| 9 | Bhat Bio-tech Manufacturer of diagnostic kits, OTC products, and reagents | — | $3M FY2025 | +92% | 86 | 1994 | Shama Bhat Founder & Managing Director | — |
| 10 | Allied Biotech Provider of diagnostic devices and reagents | — | $3M FY2022 | — | — | 2008 | Manohar patidar CEO | — |
| 11 | Biogenuix Provides research reagent for clinical diagnostic and life science research | — | $3M FY2022 | — | 33 33 → 52 (+58%) | 2004 | Sundeep Amar Co-Founder & Director | — |
| 12 | Kamineni Life Sciences Diagnostic reagent and kits manufacturers | — | $2M FY2021 | — | — | 2006 | Sumeet Roy CEO | — |
| 13 | Labcare Diagnostics Manufacturer of In‐vitro diagnostic tests and reagents | — | $2M FY2025 | -14% | — | 1982 | Parmanand Bhatia Co-Founder & Director | — |
| 14 | DCLS Provider of marketing diagnostic products catering to all segments of in vitro diagnostics | — | $2M FY2025 | +47% | — | 2021 | Vikas Kothari Founder & CEO & Managing Director | — |
| 15 | Analytical Technologies Provider of analytical devices | — | $1M FY2025 | +12% | 41 | 1972 | — | 2 launchs · 2 partnerships |
| 16 | Ark Diagnostic System Manufacturer and marketer of diagnostic products | — | $1M FY2025 | -20% | 48 | 1988 | — | — |
| 17 | Jeev Diagnostics IVD reagent manufacturer | — | $950K FY2024 | — | 21 | 2010 | R Panchanath Managing Director | — |
| 18 | Genuine X-Ray & Radiological Equipments | — | $859K FY2025 | +45% | 10 | 2004 | Nirav Lala CEO & MD | — |
| 19 | Asritha Diatech R&D company focused on manufacturing of diagnostic products | — | $795K FY2022 | — | 4 | 2008 | — | — |
| 20 | Excel Diagnostics Manufacturer of analyzers and lateral flow test | — | $448K FY2025 | +5% | 17 | 1999 | Narayana Rao Marni Founder & Owner | — |
| 21 | Achira Provider of diagnostic medical devices for screening Covid 19 | $10M | $444K FY2025 | +269% | 46 46 → 60 (+30%) | 2009 | Suri . Co-Founder | 3 job openings · 1 award |
| 22 | ADI Diagnostics Reagents for IVD and rapid diagnostic tests | — | $358K FY2022 | — | 2 | 2002 | Bs Reddy CEO | — |
| 23 | Isotope Imaging Company that provides products and services in the field of diagnostics, therapy, and theranostics in nuclear… | — | $336K FY2025 | — | — | 2016 | Sudhir Verma Founder & CEO | 1 partnership |
Top 9 Diversified Diagnostics companies in India
#1
Series B · Bengaluru, Karnataka · founded 2009 · 46 employees$10Mraised▾
Provider of diagnostic medical devices for screening Covid 19. Platform combines disposable plastic components with embedded dry reagents and a cloud-connected fluorescent scanner, allowing for efficient testing at the point of care. Company developing fabric-based lateral flow assays that utilize woven materials for diagnostic testing.
#2
Seed · Hyderabad, Telangana · founded 2017$44.3Kraised▾
Developer of nanomedicine phytopharmaceuticals & biopharmaceuticals for immunology and smart devices addressing sustainable wellness. The company invested in R&D aimed at combating vector-borne diseases with an ambitious goal of eradicating malaria through hepatic targeted nanoencapsulated phytopharmaceuticals. Its AI-powered vector surveillance devices offers real-time mosquito monitoring in homes, malls, schools, and hospitals.
- Jan 2026Seed$44.3K
#3
Series A · Haryana · founded 2003 · 375 employees$4.7Mraised▾
Medsource Ozone Biomedicals manufactures and markets a variety of IVD products. The company's product portfolio includes Analyzers such as Clinical chemistry, Hematology, Electrolyte, Immunology Hemostasis, and Urinalysis; Reagents (Clinical Chemistry, Serology, Immunoturbidimetry, Calibration / Quality control sera, Human GmbH manufactured Chemistry/Serology reagents, Human GmbH ELISA kits, Human GmbH Hemostasis reagents); lateral flow test for detection of Infectious diseases, Sexually transmitted diseases, Fertility, Cardiac markers, Urinalysis, and Rheumatology; Immunofluorescence and Line Blots for detection of autoimmune diseases. In addition, it offers POC devices for HbA1c analysis, Hemoglobin, Glucose, Blood pressure monitor, Thermometer, and Nebulizers and the molecular diagnostic products (Nucleic acid extraction systems, BoBs (BACs-on-Beads) assays, Microarray platforms, and Fragile X Syndrome diagnostic test).
#4
Seed · Pune, Maharashtra · founded 2008 · 57 employees$1.8Mraised▾
Provider of diagnostic solutions for infectious diseases, cancers, and genetic disorders. The product portfolio includes DNA and RNA-based tests for infectious diseases, oncology, endocrinology, transplantation typing, hematology, pharmacogenetics, and pre-natal and pre-implantation genetic testing. The company is also involved in the detection of HPV, COVID-19 infection among others.
- Nov 2020Grant (prize money)$336.9K
- 2020Seed—
- May 2017Seed$417.2K
- Feb 2016Seed$294.4K
#5
Early Stage · Delhi, Delhi · founded 1995 · 93 employees$2.9Mraised▾
Rapid Diagnostics is an Indian group of companies engaged in the development and manufacture of a wide range of IVD analyzers, POC diagnostic devices and monitoring equipment for critical care. The company's portfolio includes analyzers for biochemical assays, haematology, coagulation assays, urinalysis, electrolyte analysis, HbA1c analyzers, rapid tests, POC glucometers, POC and hand-held haemoglobinometers, BP instruments, and related consumables and kits. In their critical care portfolio are included multi-parameter patient monitoring systems, EGC machines, fetal Doppler monitors, pulse oximeters, defibrillators, ventilators, oxygen concentrators, and sleep apnoea therapy devices.
- Mar 2014Unattributed$1.2M
- Mar 2012Unattributed$1M
- Mar 2011Unattributed$378K
- Jan 2007Unattributed$318.1K
#6
Seed · Bengaluru, Karnataka · founded 2016 · 5 employees$281.8Kraised▾
Developer of non-invasive diagnostic solutions for neonatal sepsis. The company is developing a non-invasive diagnostic solution to help the diagnosis of sepsis in neonates and is in stealth mode.
- Nov 2022Seed$157.8K
- Sep 2020Seed$81K
- Dec 2018Seed$43K
- Feb 2017Seed—
#7
Funding Raised · Vadodara, Gujarat · founded 1972 · 41 employees—raised▾
Analytical Group provides analytical devices. The company offers a range of chromatography, spectroscopy, biotechnology, biomedical, clinical diagnostics, material science, consumables, and general lab equipment.
#8
Funding Raised · Bengaluru, Karnataka · founded 2013—raised▾
X-Ray imaging systems
#9
Funding Raised · Mumbai, Maharashtra · founded 1979 · 1295 employees—raised▾
Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutions. It offers a wide range of products that cater to various medical fields, including hematology, clinical chemistry, immunology, critical care, diabetes, urinalysis, molecular diagnostics, microbiology, ESR, and blood banking.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Diversified Diagnostics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.